Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
CVS Health
CVS
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Stock
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.


























| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | CVS Health CVS Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Kenvue KVUE | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | UnitedHealth Group UNH Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Thermo Fisher Scientific TMO Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Boston Scientific BSX Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Cigna CI The Cigna Group | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | McKesson MCK Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | McKesson MCK Stock | Sep 10, 2025 30 days to disclose | Good buy·+$382+4.8% −3.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Thermo Fisher Scientific TMO Stock | Jun 6, 2025 98 days to disclose · 53 past 45-day window | Good buy·+$1.4K+17.7% +7.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | UnitedHealth Group UNH Common Stock | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | UnitedHealth Group UNH Common Stock | Apr 29, 2025 136 days to disclose · 91 past 45-day window | Bad buy·−$554-6.9% −13.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | UnitedHealth Group UNH Common Stock | Apr 15, 2025 150 days to disclose · 105 past 45-day window | Bad buy·−$2.8K-34.7% −42.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Thermo Fisher Scientific TMO Stock | Mar 3, 2025 193 days to disclose · 148 past 45-day window | Flat·+0.0% −0.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | UnitedHealth Group UNH Common Stock | Jan 24, 2025 231 days to disclose · 186 past 45-day window | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Elevance Health ELV Elevance Health, Inc. | Jan 13, 2025 242 days to disclose · 197 past 45-day window | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | HCA Healthcare HCA HCA Healthcare, Inc. | Dec 27, 2024 259 days to disclose · 214 past 45-day window | Flat·+0.0% +6.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Kenvue KVUE | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$1.9K-23.2% −23.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Danaher DHR | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$2.3K-28.7% −28.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | CVS Health CVS Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$4.9K+60.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Elevance Health ELV Elevance Health, Inc. | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$706-8.8% −8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | HCA Healthcare HCA HCA Healthcare, Inc. | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$1.6K+20.6% +20.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Cigna CI The Cigna Group | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$914-11.4% −11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Thermo Fisher Scientific TMO Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$1.1K-13.7% −13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Boston Scientific BSX Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$3.6K-44.8% −44.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | UnitedHealth Group UNH Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$2.6K-32.2% −32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Centene CNC | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$920-11.5% −11.6% vs S&P 500 | $1K-$15K midpoint $8K |